Maravai Lifesciences Holdings Inc (MRVI) — Cash Flow Quality Index
Maravai Lifesciences Holdings Inc (MRVI) has a Cash Flow Quality Index of 1.14x as of December 2022. Operating cash flow of $99.33 Million exceeds net income of $87.43 Million, indicating high earnings quality where cash backs reported profits. Explore MRVI operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Maravai Lifesciences Holdings Inc Cash Flow Quality Index (2020–2022)
Historical Cash Flow Quality Index for Maravai Lifesciences Holdings Inc across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Maravai Lifesciences Holdings Inc operating cash flow efficiency.
Annual Cash Flow Quality Index for Maravai Lifesciences Holdings Inc (2020–2022)
Year-by-year earnings quality comparison for Maravai Lifesciences Holdings Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 1.09x | $535.98 Million | $490.66 Million | ▲ +39.1% |
| 2021 | 0.79x | $368.57 Million | $469.25 Million | ▼ -59.3% |
| 2020 | 1.93x | $152.19 Million | $78.82 Million | — |